Rational Study Endpoint(s) for Preoperative Trials in Pancreatic Cancer: Pathologic Response Rate, Margin Negative Resection, Overall Survival or ‘All of the Above’?
Annals of Surgical Oncology - United States
doi 10.1245/s10434-013-3165-5
Full Text
Open PDFAbstract
Available in full text
Date
August 14, 2013
Authors
Publisher
Springer Science and Business Media LLC